- Home
- AVIR vs BEAG Comparison
AVIR vs BEAG Comparison
Compare AVIR & BEAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- BEAG
- Stock Information
- Founded
- AVIR 2012
- BEAG 2021
- Country
- AVIR United States
- BEAG United States
- Employees
- AVIR N/A
- BEAG N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- BEAG
- Sector
- AVIR Health Care
- BEAG
- Exchange
- AVIR Nasdaq
- BEAG NYSE
- Market Cap
- AVIR 273.7M
- BEAG 317.4M
- IPO Year
- AVIR 2020
- BEAG 2024
- Fundamental
- Price
- AVIR $2.97
- BEAG $10.38
- Analyst Decision
- AVIR Hold
- BEAG
- Analyst Count
- AVIR 1
- BEAG 0
- Target Price
- AVIR $6.00
- BEAG N/A
- AVG Volume (30 Days)
- AVIR 441.1K
- BEAG 211.6K
- Earning Date
- AVIR 05-12-2025
- BEAG 01-01-0001
- Dividend Yield
- AVIR N/A
- BEAG N/A
- EPS Growth
- AVIR N/A
- BEAG 196.66
- EPS
- AVIR N/A
- BEAG 0.26
- Revenue
- AVIR N/A
- BEAG N/A
- Revenue This Year
- AVIR N/A
- BEAG N/A
- Revenue Next Year
- AVIR N/A
- BEAG N/A
- P/E Ratio
- AVIR N/A
- BEAG $40.12
- Revenue Growth
- AVIR N/A
- BEAG N/A
- 52 Week Low
- AVIR $2.46
- BEAG $9.84
- 52 Week High
- AVIR $4.15
- BEAG $11.20
- Technical
- Relative Strength Index (RSI)
- AVIR 56.05
- BEAG N/A
- Support Level
- AVIR $2.78
- BEAG N/A
- Resistance Level
- AVIR $3.03
- BEAG N/A
- Average True Range (ATR)
- AVIR 0.17
- BEAG 0.00
- MACD
- AVIR 0.03
- BEAG 0.00
- Stochastic Oscillator
- AVIR 88.03
- BEAG 0.00
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About BEAG BOLD EAGLE ACQUISITION CORP
Bold Eagle Acquisition Corp is a blank check company.